Pharmaceutical Antitrust in India India’s pharmaceutical sector operates at the intersection of public health regulation and competition law enforcement. As one of the world’s largest producers of generic medicines, the industry is subject to a comprehensive legal framework designed to ensure the safety, affordability, and availability of medicines while preserving fair market competition. Pharmaceutical companies must comply with regulations governing drug approvals, manufac

BACKGROUND Press Note 3 (2020) (" PN3 ") was issued by the Department for Promotion of Industry and Internal Trade (" DPIIT ") in April 2020, primarily to curb opportunistic takeovers and acquisitions of Indian companies during the COVID-19 pandemic. PN3 amended Para 3.1.1 of the Consolidated FDI Policy Circular of 2020 (" FDI Policy ") to require all investments from countries sharing a land border with India (" LBCs ") [1] to be made only under the Government route, i.e.,

BACKGROUND Introduced during the COVID-19 pandemic to curb opportunistic takeovers of Indian companies, Press Note 3 of 2020 (" PN3 ") mandated prior approval from the government for all foreign direct investment, whether direct or indirect, where the investor or its beneficial owner is situated in or is a citizen of a country sharing a land border with India (" LBC ") [1] . While the restrictions under PN3 were largely aimed at investments from China, in reality, these restr

On 16 February 2026, the Reserve Bank of India (“ RBI ”) notified the Foreign Exchange Management (Borrowing and Lending) (First Amendment) Regulations, 2026 (the “ New ECB Framework ”), which came into force with immediate effect from the date of notification. The New ECB Framework constitutes one of the most comprehensive overhauls of India’s external commercial borrowing (“ ECB ”) framework to date. The principal changes introduced pursuant to the New ECB Framework are sum

On 10 th February 2026, the Ministry of Electronics and Information Technology ( "MeitY" ) notified the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Amendment Rules, 2026 ( "Notified Rules" ) to regulate synthetically generated information ( “SGI” ), including deepfakes and other AI-generated content, and to impose enhanced due diligence obligations on intermediaries and Significant Social Media Intermediaries ( “SSMI” ). The notification o

This edition distils the most relevant recent developments in real estate across the Supreme Court, High Courts, RERA authorities, and key regulators—viewed through the lens of what matters most for developers, investors, lenders, and in-house teams. From title certainty and registration reforms to RERA enforcement trends, insolvency interplay, and evolving compliance frameworks, we translate legal change into practical insights for decision-makers. If you track India’s r

Chandhiok & Mahajan, Advocates and Solicitors advised IAN Group on its investment in Chargeup (“ Company ”). The investment by IAN Angel Fund was part of a funding round conducted by the Company worth INR 22 crores. The Company is involved in building a platform for supporting EV 3-wheeler operators in various operational aspects such as providing assistance with battery financing, as well as connecting OEMs, dealers and drivers. The C&M team members advising on this transa

Chandhiok & Mahajan, Advocates and Solicitors Restructuring & Insolvency Team, led by Pooja Mahajan –Partner and Head of Restructuring & Insolvency Practice, assisted by Nishant Sogani, Partner, Savar Mahajan, Managing Associate, Saurabh Bachhawat, Managing Associate, Srivatsav Reddy Beerapalli, Associate and Poojal Agarwal, Associate, advised Mr. TrupalKumar Patel, the Resolution Professional of Ushdev Engitech Limited in successful completion of its corporate insolvency res